Stefania Girotto

19PUBLICATIONS
73CO-AUTHORS
Characterisation of biological macromoleculesMolecular targetsBiologically active moleculesGenome structure and regulationEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Apr 29, 2026
A Polypharmacology-Driven Approach to Alzheimer's Disease and Tauopathies: Rational Design, Synthesis and Characterization of Amino-Pyrazole-Based Multikinase (GSK-3β/FYN-α/DYRK1A) Inhibitors.

|Feb 18, 2026
Targeting RAD51-BRCA2 Interaction to Enhance Synthetic Lethality with Olaparib in Pancreatic Cancer: Development of a Novel Phenyl Furan-Quinoline-Carboxylic Acid Series.

Giovanni Ferrandi, Greta Bagnolini, Laura Poppi

|Feb 13, 2026
A Metabolites' Interplay Can Modulate DNA Repair by Homologous Recombination.

Valentina Rossi, Mirco Masi, Marzia Govoni

|Jan 20, 2026
Correction: Chronic administration of Metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells.

Francesca Cianci, Ivan Verduci, Riccardo Cazzoli

|Dec 01, 2025
Computationally-designed aptamers targeting RAD51-BRCA2 interaction impair homologous recombination and induce synthetic lethality.

Giulia Milordini, Elsa Zacco, Mirco Masi

|Nov 23, 2025
Chronic administration of metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells.

Francesca Cianci, Ivan Verduci, Riccardo Cazzoli

Pageof 4

Frequent Collaborators

11 joint publications

Andrea Cavalli

6 joint publications

Beatrice Balboni

5 joint publications

Marina Veronesi

4 joint publications

Mirco Masi